Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Please Note: MicroBiome Restore Is Not a GLP-1 Medication or Weight-Loss Product The research summarized above describes individual fibers, foods, and probiotic strains studied in laboratory, animal, and clinical settings it does not describe outcomes for this or any specific product, and effect sizes in these studies are generally modest
Patients interested in accessing retatrutide should speak to their GP or a specialist, who can advise on whether any ongoing clinical trials may be appropriate and how to access them through legitimate NHS or academic research pathways
Assessing risk of bias in included studies
Who Should Not Switch Patients with active or recent pancreatitis, personal or family history of medullary thyroid carcinoma (MTC), or multiple endocrine neoplasia type 2 (MEN2) should not be initiated on any GLP-1 receptor agonist, including retatrutide [4]
Existing Therapies For UK clinicians, the choice between semaglutide, tirzepatide, and the forthcoming retatrutide will be determined by a balance of efficacy, tolerability, and cost-effectiveness
